Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assurant (AIZ) Cash & Equivalents (2016 - 2025)

Assurant has reported Cash & Equivalents over the past 17 years, most recently at $1.8 billion for Q4 2025.

  • Quarterly results put Cash & Equivalents at $1.8 billion for Q4 2025, up 1.46% from a year ago — trailing twelve months through Dec 2025 was $1.8 billion (up 1.46% YoY), and the annual figure for FY2025 was $1.8 billion, up 1.46%.
  • Cash & Equivalents for Q4 2025 was $1.8 billion at Assurant, up from $1.7 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for AIZ hit a ceiling of $2.7 billion in Q2 2021 and a floor of $1.2 billion in Q2 2022.
  • Median Cash & Equivalents over the past 5 years was $1.6 billion (2021), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Cash & Equivalents: soared 30.27% in 2021 and later plummeted 56.96% in 2022.
  • Assurant's Cash & Equivalents stood at $2.0 billion in 2021, then dropped by 24.7% to $1.5 billion in 2022, then rose by 5.9% to $1.6 billion in 2023, then grew by 11.08% to $1.8 billion in 2024, then increased by 1.46% to $1.8 billion in 2025.
  • The last three reported values for Cash & Equivalents were $1.8 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.